Iliac Stent Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

The Iliac Stent Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Iliac Stent Market?
The iliac stent market has grown significantly in recent years. It will expand from $1.02 billion in 2024 to $1.09 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth is due to the global expansion of healthcare, increased awareness of minimally invasive procedures, rising demand for stenting procedures, the growing incidence of iliac artery diseases, and improved healthcare infrastructure.

The iliac stent market is expected to see strong growth, reaching $1.43 billion by 2029 at a CAGR of 6.9%. The growth is driven by the rising prevalence of peripheral artery diseases, the growing geriatric population, increased angioplasty procedures, the demand for less invasive procedures, and the rise in diabetes cases. Key trends include technological advancements in iliac stents, more product approvals, advancements in medical technology, expanding distribution networks, and the adoption of iliac stents in outpatient settings.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15827

What Are the Different Iliac Stent Market Segments?
The iliac stent market covered in this report is segmented -

1) By Type: Self-Expandable Stents, Balloon-Expandable Stents, Other Types
2) By Artery Lesions: Common Iliac Artery Lesions, Severe Calcified Lesions, Complete Obstructive Lesions
3) By End-Users: Hospitals, Outpatient Facilities, Other End-Users

Subsegments:
1) By Self-Expandable Stents: Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents
2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents, Drug-Eluting Balloon-Expandable Stents
3) By Other Types: Covered Stents, Hybrid Stents

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15827&type=smp

What Are the Primary Drivers Shaping the Iliac Stent Market?
Similarly, the rising prevalence of peripheral artery diseases (PAD) is expected to drive the growth of the iliac stent market. PAD is a circulatory condition characterized by the narrowing or blockage of arteries outside the heart and brain. Factors such as smoking, hypertension, diabetes, and an aging population are contributing to the growing prevalence of PAD. Iliac stents provide an effective, minimally invasive treatment option for improving blood flow and preventing complications in PAD patients. According to the Society For Cardiovascular Angiography And Interventions, PAD affects millions of people annually, and its prevalence is expected to increase in the coming decades, driving demand for iliac stents.

Which Companies Are Leading in the Iliac Stent Market?
Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, dic*kinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH

What Are the Latest Developing Trends in the Iliac Stent Market?
Leading organizations in the iliac stent market are introducing pioneering products like iCast to enhance patient results and minimize the likelihood of complications. The iCast-covered stent system symbolizes a novel approach in addressing occlusive disease in the iliac artery, providing superior performance and lower complication risks than conventional bare-metal stents. For example, in October 2023, Getinge, a healthcare company headquartered in Sweden, declared the commercial availability of the iCast-covered stent system in the United States for the treatment of iliac arterial occlusive disease, as approved by the Food and Drug Administration (FDA). This announcement demonstrates Getinge's dedication to provide top-tier products and support to American clinicians and hospital systems in managing this critical condition.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report

What Are the Top Revenue-Generating Geographies in the Iliac Stent Market?
North America was the largest region in the iliac stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Iliac Stent Market?
2. What is the CAGR expected in the Iliac Stent Market?
3. What Are the Key Innovations Transforming the Iliac Stent Industry?
4. Which Region Is Leading the Iliac Stent Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.